LCLeonard Yan Ming Cheung

Leonard Yan Ming Cheung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Leonard Yan Ming Cheung has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genetic and environmental drivers of craniofacial, brain, and pituitary disorders

    by Sally A Camper, Julian Martinez-Mayer, Shalini Guha, Nooshin Mojahed, Leonard Y M Cheung, Stefan H Geyer, Michelle L Brinkmeier, Wolfgang J Weninger, Hironori Bando, Lori T Raetzman, et al.

    Congenital pituitary hormone deficiency (CH) is a rare disorder that usually involves deficient production of growth hormone (GH) and other pituitary hormones. Many cases are syndromic, affecting other aspects of craniofacial development and sometimes other organs. There are many genes implicated in congenital pituitary hormone deficiency, and some of them also cause more severe disorders like septo-optic dysplasia (SOD) and holoprosencephaly (HPE). It is not clear why mutations in the same gene can cause such variable clinical features. In addition, the molecular etiology of many cases is not identified with current genetic testing approaches. To realize the promise of the Human Genome Project, more genetic causes need to be identified, and the basis for variable clinical presentations needs to be better understood. In this review, we provide information about the overlapping genetic causes of this spectrum of disorders in humans, discuss the influence of genetic background and environment on presentations, and highlight animal models that expand our understanding of how genetic and environmental factors can synergize to generate diverse phenotypes. Evidence for genetic and environmental contributions to this spectrum of disorders is strong.

  • Loss of primary cilia in late pituitary organogenesis does not cause endocrine dysfunction

    by Kevin Byun, Yuxuan Lin, Feng‐Qian Li, Ken‐Ichi Takemaru, Leonard Y. M. Cheung

    Cilia are finger‐like organelles protruding from the cell membrane, and dysfunction of cilia can cause human diseases called ciliopathies with a range of phenotypes. Some ciliopathies include pituitary phenotypes, and previous studies have shown a role for non‐motile primary cilia in pituitary organogenesis. In this study, we generated a pituitary gland‐conditional knockout of the ciliary basal body protein CEP164 to investigate the role of primary cilia in pituitary development and postnatal function. Our mouse model shows a loss of pituitary primary cilia between e14.5 and e18.5, although pituitary organogenesis and morphology appear normal in late embryos and postpubertal mice of both sexes. No physiological defects were noted in postpubertal mice, although there were minor changes in the expression of Sox2 and Prl transcripts. We conclude that primary cilia are dispensable in late pituitary organogenesis, therefore suggesting the role of primary cilia occurs during early pituitary development. Further studies may investigate whether cilia are required for specific responses to physiological or pathological conditions where endocrine needs are altered.

  • Open Access

    Nucleoredoxin regulates WNT signaling during pituitary stem cell differentiation

    by Michelle L. Brinkmeier, Leonard Y. M. Cheung, Sean P. O’COnnell, Diana K. Gutierrez, Eve C. Rhoads, Sally A. Camper, Shannon W. Davis

    Nucleoredoxin ( Nxn ) encodes a multi-functional enzyme with oxidoreductase activity that regulates many different signaling pathways and cellular processes in a redox-dependent manner. Rare NXN mutations are reported in individuals with recessive Robinow syndrome, which involves mesomelic skeletal dysplasia, short stature, craniofacial dysmorphisms, and incompletely penetrant heart and palate defects. Here we report that Nxn is expressed in the ventral diencephalon and developing pituitary gland, and that Nxn deficient mice have pituitary dysmorphology and craniofacial abnormalities that include defects in the skull base and cleft palate. Nxn mutant mice exhibit reduced WNT signaling and reduced differentiation of pituitary stem cells into hormone-producing cells. These results suggest patients with Robinow syndrome could benefit from evaluation by endocrinologists for pituitary structural imaging and hormone insufficiency. Highlights: Nxn deficiency causes neonatal lethality, cleft palate, craniofacial abnormalities, and other structural birth defects. Nxn deficiency causes pituitary dysmorphology. Analysis of scRNA seq reveals delayed trajectory during early pituitary cell differentiation. Nxn deficiency reduces canonical and non-canonical Wnt signaling in developing pituitary glands. Nxn deficiency reduces stem cell differentiation into pituitary hormone-producing cells.


  • Long Noncoding RNAs Expressed in Mouse Pituitary Development and Mature Hormone-Producing Cells

    by Michelle Lynn Brinkmeier, Akima Semone George, Leonard Yan Ming Cheung, Ryan Edward Mills, Philippa Melamed, Sally Ann Camper

    Mammalian genomes contain thousands of genes for long non-coding RNA (lncRNAs), some of which have been shown to affect protein-coding gene expression through diverse mechanisms. The lncRNA transcripts are longer than 200 nucleotides and are often capped, spliced and polyadenylated, but not translated into protein. Nuclear lncRNAs can modify chromatin structure and transcription in trans or cis by interacting with the DNA, forming R-loops, and recruiting regulatory proteins. Not much is known about the role of lncRNA in pituitary gland differentiation and function. We mined transcriptome data from mouse pituitary glands collected at embryonic days 12.5 and 14.5 and identified over 200 different lncRNA transcripts. To develop a research resource for the study of lncRNA, we used pituitary cre transgenes to tag pituitary cell types in adult mice with fluorescent markers, and enriched for thyrotropes, gonadotropes, and somatotropes using fluorescence activated cell sorting. We determined the transcriptome of each cell population using RNA sequencing and mined the data for lncRNA. We detected hundreds of lncRNAs in adult pituitary cells, a few were located immediately nearby genes that encode pituitary hormones or lineage-specific transcription factors. The location of these lncRNAs suggests the possibility of a cis-acting regulatory role in pituitary development or function, and we observe coordinated expression of two of them with their putative target genes in transgenic mice. This research resource sets the foundation for examining the actions of lncRNAs on their putative target genes and determining whether they have roles during development and in response to physiological demand.


  • Open Access

    Gene Misexpression in a Smoc2+ve/Sox2-Low Population in Juvenile Prop1-Mutant Pituitary Gland

    by Bailey E Masser, Michelle L Brinkmeier, Yuxuan Lin, Qin Liu, Aya Miyazaki, Jannatun Nayeem, Leonard Y M Cheung

    Mutations in the pituitary specific transcription factor Prophet of Pit-1 (PROP1) are the most common genetic etiology of combined pituitary hormone deficiency (CPHD). CPHD is associated with short stature, attributable to growth hormone deficiency and/or thyroid stimulating hormone deficiency, as well as hypothyroidism and infertility. Pathogenic lesions impair pituitary development and differentiation of endocrine cells. We performed single-cell RNA sequencing of pituitary cells from a wild-type and a Prop1-mutant P4 female to elucidate population-specific differential gene expression. We observed a Smoc2+ve population that expressed low Sox2, which trajectory analyses suggest are a transitional cell state as stem cells differentiate into endocrine cells. We also detected ectopic expression of Sox21 in these cells in the Prop1df/df mutant. Prop1-mutant mice are known to overexpress Pou3f4, which we now show to be also enriched in this Smoc2+ve population. We sought to elucidate the role of Pou3f4 during pituitary development and to determine the contributions of Pou3f4 upregulation to pituitary disease by utilizing double-mutant mice lacking both Prop1 and Pou3f4. However, our data showed that Pou3f4 is not required for normal pituitary development and function. Double mutants further demonstrated that the upregulation of Pou3f4 was not causative for the overexpression of Sox21. These data indicate loss of Pou3f4 is not a potential cause of CPHD, and further studies may investigate the functional consequence of upregulation of Pou3f4 and Sox21, if any, in the novel Smoc2+ve cell population.


  • Open Access

    Myelin regulatory factor ( Myrf ) is a critical early regulator of retinal pigment epithelial development

    by Michelle L. Brinkmeier, Su Qing Wang, Hannah Pittman, Leonard Y. Cheung, Lev Prasov

    Myelin regulatory factor (Myrf) is a critical transcription factor in early retinal and retinal pigment epithelial development, and human variants in MYRF are a cause for nanophthalmos. Single cell RNA sequencing (scRNAseq) was performed on Myrf conditional knockout mice ( Rx>Cre Myrf fl/fl ) at 3 developmental timepoints. Myrf was expressed specifically in the RPE, and expression was abrogated in Rx>Cre Myrf fl/fl eyes. scRNAseq analysis revealed a loss of RPE cells at all timepoints resulting from cell death. GO-term analysis in the RPE revealed downregulation of melanogenesis and anatomic structure morphogenesis pathways, which were supported by electron microscopy and histologic analysis. Novel structural target genes including Ermn and Upk3b , along with macular degeneration and inherited retinal disease genes were identified as downregulated, and a strong upregulation of TGFß/BMP signaling and effectors was observed. Regulon analysis placed Myrf downstream of Pax6 and Mitf and upstream of Sox10 in RPE differentiation. Together, these results suggest a strong role for Myrf in the RPE maturation by regulating melanogenesis, cell survival, and cell structure, in part acting through suppression of TGFß signaling and activation of Sox10 . SUMMARY STATEMENT: Myrf regulates RPE development, melanogenesis, and is important for cell structure and survival, in part through regulation of Ermn , Upk3b and Sox10, and BMP/TGFb signaling.

  • Open Access

    Editorial: New advances on hypothalamus-pituitary stem cell biology

    by Leonard Cheung, Shannon W. Davis, Maria Ines Perez-Millan

    New advances on hypothalamus-pituitary stem cell biology The discovery of stem cells in many tissues including the pituitary and hypothalamus has presented the potential for stem cell regeneration and treatment for human diseases. However, significant gaps in knowledge remain in our understanding of the full range of molecular mechanisms that regulate the progression of these stem cells into the desired celltypes, limiting the translatability of basic science into human therapies. The articles in this Research Topic present novel data and review recent discoveries from a combination of human genetic studies, human organoid models and mouse models to improve our understanding of hypothalamic-pituitary stem cell regulation. The median eminence of the hypothalamus is the critical interface between the brain and the pituitary gland. In addition to neurons, it contains multiple non-neural cell-types including oligodendrocyte precursors and stem cell-like b2-tanycytes. In Clayton et al. the authors discuss recent discoveries regarding these various cell-types and their regulatory mechanisms, including the role of diet on tanycytes, as well as future questions that remain as we continue to understand the central role of the median eminence in the neuroendocrine system. Improvements in genomic sequencing techniques have continued to increase the number of genetic variants associated with hypothalamic-pituitary disease. Functional studies can subsequently demonstrate the mechanisms by which genes regulate stem cell differentiation into differentiated cells. In Martinez-Mayer and Perez-Millan the authors review the changing landscape of patients described with variants in the G-coupled receptor PROKR2, which were originally discovered to cause hypothalamic phenotypes in Kallman syndrome patients. More recently PROKR2 variants have been associated with pituitary disease, leading the authors to consider a direct role in regulating pituitary hormone cell specification. In Bando et al. the authors review recent cases describing novel genes associated with pituitary disease that require functional studies to determine the mechanisms that disrupt hormone production including possible involvement of pituitary Frontiers in Endocrinology frontiersin.org 01

  • Pituitary stem cells: past, present and future perspectives

    by María Inés Pérez Millán, Leonard Y. M. Cheung, Florencia Mercogliano, Maria Andrea Camilletti, Gonzalo T. Chirino Felker, Lucia N. Moro, Santiago Miriuka, Michelle L. Brinkmeier, Sally A. Camper

    Pituitary cells that express the transcription factor SOX2 are stem cells because they can self-renew and differentiate into multiple pituitary hormone-producing cell types as organoids. Wounding and physiological challenges can activate pituitary stem cells, but cell numbers are not fully restored, and the ability to mobilize stem cells decreases with increasing age. The basis of these limitations is still unknown. The regulation of stem cell quiescence and activation involves many different signalling pathways, including those mediated by WNT, Hippo and several cytokines; more research is needed to understand the interactions between these pathways. Pituitary organoids can be formed from human or mouse embryonic stem cells, or from human induced pluripotent stem cells. Human pituitary organoid transplantation is sufficient to induce corticosterone release in hypophysectomized mice, raising the possibility of therapeutic applications. Today, pituitary organoids have the potential to assess the role of individual genes and genetic variants on hormone production ex vivo, providing an important tool for the advancement of exciting frontiers in pituitary stem cell biology and pituitary organogenesis. In this article, we provide an overview of notable discoveries in pituitary stem cell function and highlight important areas for future research.


  • Novel Candidate Regulators and Developmental Trajectory of Pituitary Thyrotropes

    by Leonard Y M Cheung, Lucy Menage, Karine Rizzoti, Greg Hamilton, Typhanie Dumontet, Kaitlin Basham, Alexandre Z Daly, Michelle L Brinkmeier, Bailey E Masser, Mathias Treier, et al.

    The pituitary gland regulates growth, metabolism, reproduction, the stress response, uterine contractions, lactation, and water retention. It secretes hormones in response to hypothalamic input, end organ feedback, and diurnal cues. The mechanisms by which pituitary stem cells are recruited to proliferate, maintain quiescence or differentiate into specific cell types, especially thyrotropes, are not well understood. We utilized single-cell RNA sequencing in juvenile P7 mouse pituitary cells to identify novel factors in pituitary cell populations, with a focus on thyrotropes and rare subtypes. We first observed cells co-expressing markers of both thyrotropes and gonadotropes, such as Pou1f1 and Nr5a1. This was validated in vivo by both immunohistochemistry and lineage tracing of thyrotropes derived from Nr5a1-Cre; mTmG mice and demonstrates that Nr5a1-progenitors give rise to a proportion of thyrotropes during development. Our dataset also identifies novel factors expressed in pars distalis and pars tuberalis thyrotropes, including the Shox2b isoform in all thyrotropes and Sox14 specifically in Pou1f1-negative pars tuberalis thyrotropes. We have therefore used single-cell transcriptomics to determine a novel developmental trajectory for thyrotropes and potential novel regulators of thyrotrope populations.


  • Biology of Pituitary Stem Cells

    by María Inés Pérez Millán, Leonard Y.M. Cheung, Sally A. Camper